Literature DB >> 20814186

Parameters governing invasive disease propensity of non-M1 serotype group A streptococci.

Peter G Maamary1, Martina L Sanderson-Smith, Ramy K Aziz, Andrew Hollands, Jason N Cole, Fiona C McKay, Jason D McArthur, Joshua K Kirk, Amanda J Cork, Rachael J Keefe, Rita G Kansal, Hongmin Sun, William L Taylor, Gursharan S Chhatwal, David Ginsburg, Victor Nizet, Malak Kotb, Mark J Walker.   

Abstract

Group A Streptococcus (GAS) causes rare but life-threatening syndromes of necrotizing fasciitis and toxic shock-like syndrome in humans. The GAS serotype M1T1 clone has globally disseminated, and mutations in the control of virulence regulatory sensor kinase (covRS) operon correlate with severe invasive disease. Here, a cohort of non-M1 GAS was screened to determine whether mutation in covRS triggers systemic dissemination in divergent M serotypes. A GAS disease model defining parameters governing invasive propensity of differing M types is proposed. The vast majority of GAS infection is benign. Nonetheless, many divergent M types possess limited capacity to cause invasive infection. M1T1 GAS readily switch to a covRS mutant form that is neutrophil resistant and frequently associated with systemic infection. Whilst non-M1 GAS are shown in this study to less frequently accumulate covRS mutations in vivo, such mutants are isolated from invasive infections and exhibit neutrophil resistance and enhanced virulence. The reduced capacity of non-M1 GAS to switch to the hypervirulent covRS mutant form provides an explanation for the comparatively less frequent isolation of non-M1 serotypes from invasive human infections.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814186      PMCID: PMC3219504          DOI: 10.1159/000317640

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  42 in total

1.  Growth-phase-dependent expression of virulence factors in an M1T1 clinical isolate of Streptococcus pyogenes.

Authors:  M Unnikrishnan; J Cohen; S Sriskandan
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.

Authors:  D R Johnson; D L Stevens; E L Kaplan
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

3.  Genetic locus for streptolysin S production by group A streptococcus.

Authors:  V Nizet; B Beall; D J Bast; V Datta; L Kilburn; D E Low; J C De Azavedo
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 4.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

5.  Experimental anticancer studies. XXX. Factors influencing the streptolysin S-forming ability of streptococci having anticancer activity.

Authors:  H Okamoto; S Shoin; M Minami; S Koshimura; R Shimizu
Journal:  Jpn J Exp Med       Date:  1966-04

Review 6.  Is plasminogen deployed as a Streptococcus pyogenes virulence factor?

Authors:  Mark J Walker; Jason D McArthur; Fiona McKay; Marie Ranson
Journal:  Trends Microbiol       Date:  2005-07       Impact factor: 17.079

7.  Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.

Authors:  Hongmin Sun; Ulrika Ringdahl; Jonathon W Homeister; William P Fay; N Cary Engleberg; Angela Y Yang; Laura S Rozek; Xixi Wang; Ulf Sjöbring; David Ginsburg
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

8.  Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB.

Authors:  Ramy K Aziz; Michael J Pabst; Arthur Jeng; Rita Kansal; Donald E Low; Victor Nizet; Malak Kotb
Journal:  Mol Microbiol       Date:  2004-01       Impact factor: 3.501

9.  Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.

Authors:  J C Levin; M R Wessels
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

10.  DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection.

Authors:  Mark J Walker; Andrew Hollands; Martina L Sanderson-Smith; Jason N Cole; Joshua K Kirk; Anna Henningham; Jason D McArthur; Katrin Dinkla; Ramy K Aziz; Rita G Kansal; Amelia J Simpson; John T Buchanan; Gursharan S Chhatwal; Malak Kotb; Victor Nizet
Journal:  Nat Med       Date:  2007-07-15       Impact factor: 53.440

View more
  21 in total

1.  Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone.

Authors:  Peter G Maamary; Nouri L Ben Zakour; Jason N Cole; Andrew Hollands; Ramy K Aziz; Timothy C Barnett; Amanda J Cork; Anna Henningham; Martina Sanderson-Smith; Jason D McArthur; Carola Venturini; Christine M Gillen; Joshua K Kirk; Dwight R Johnson; William L Taylor; Edward L Kaplan; Malak Kotb; Victor Nizet; Scott A Beatson; Mark J Walker
Journal:  FASEB J       Date:  2012-08-09       Impact factor: 5.191

2.  Characterization of the effect of the histidine kinase CovS on response regulator phosphorylation in group A Streptococcus.

Authors:  Nicola Horstmann; Pranoti Sahasrabhojane; Miguel Saldaña; Nadim J Ajami; Anthony R Flores; Paul Sumby; Chang-Gong Liu; Hui Yao; Xiaoping Su; Erika Thompson; Samuel A Shelburne
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

3.  Unique genomic arrangements in an invasive serotype M23 strain of Streptococcus pyogenes identify genes that induce hypervirulence.

Authors:  Yunjuan Bao; Zhong Liang; Claire Booyjzsen; Jeffrey A Mayfield; Yang Li; Shaun W Lee; Victoria A Ploplis; Hui Song; Francis J Castellino
Journal:  J Bacteriol       Date:  2014-09-15       Impact factor: 3.490

Review 4.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

Review 5.  Group A Streptococcus encounters with host macrophages.

Authors:  J Andrés Valderrama; Victor Nizet
Journal:  Future Microbiol       Date:  2017-12-11       Impact factor: 3.165

6.  Molecular characterization of the 2011 Hong Kong scarlet fever outbreak.

Authors:  Herman Tse; Jessie Y J Bao; Mark R Davies; Peter Maamary; Hoi-Wah Tsoi; Amy H Y Tong; Tom C C Ho; Chi-Ho Lin; Christine M Gillen; Timothy C Barnett; Jonathan H K Chen; Mianne Lee; Wing-Cheong Yam; Chi-Kin Wong; Cheryl-Lynn Y Ong; Yee-Wai Chan; Cheng-Wei Wu; Tony Ng; Wilina W L Lim; Thomas H F Tsang; Cindy W S Tse; Gordon Dougan; Mark J Walker; Si Lok; Kwok-Yung Yuen
Journal:  J Infect Dis       Date:  2012-05-21       Impact factor: 5.226

7.  Association between polymorphisms in the csrRS two-component regulatory system and invasive group A streptococcal infection.

Authors:  J-N Lin; L-L Chang; C-H Lai; H-H Lin; Y-H Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-26       Impact factor: 3.267

8.  Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus.

Authors:  James A Tsatsaronis; Andrew Hollands; Jason N Cole; Peter G Maamary; Christine M Gillen; Nouri L Ben Zakour; Malak Kotb; Victor Nizet; Scott A Beatson; Mark J Walker; Martina L Sanderson-Smith
Journal:  FASEB J       Date:  2013-03-26       Impact factor: 5.191

9.  Acquisition of the Sda1-encoding bacteriophage does not enhance virulence of the serotype M1 Streptococcus pyogenes strain SF370.

Authors:  Carola Venturini; Cheryl-Lynn Y Ong; Christine M Gillen; Nouri L Ben-Zakour; Peter G Maamary; Victor Nizet; Scott A Beatson; Mark J Walker
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

Review 10.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.